Training in MHealth Prevention with MSM
MSM 的 MHealth 预防培训
基本信息
- 批准号:10673645
- 负责人:
- 金额:$ 18.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-15 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAccelerationAcquired Immunodeficiency SyndromeAddressAgeAmphetaminesApplied SkillsAreaAsiaBiometryCareer ChoiceCareer MobilityCaringCellular PhoneClinicCompetenceCountryCoupledDecision MakingDevelopmentDiffusionDiscriminationDrug usageEnsureEnvironmentEpidemicFosteringFoundationsFrightFundingFutureGoalsGuide preventionHIVHIV InfectionsHealthHealth ProfessionalHealth PromotionHealth ServicesHealth TechnologyHealthcareHomosexualityHuman immunodeficiency virus testIncidenceIncomeInternational AgenciesInterventionInterviewJudgmentLawsLinkMalaysiaMalaysianMentorsMentorshipMethodsMotivationMuslim population groupPatient PreferencesPatientsPersonsPharmaceutical PreparationsPhasePhysiciansPopulationPrevalencePreventionPrevention strategyProductivityProviderRecommendationResearchResearch ActivityResearch PersonnelResearch Project GrantsRiskRisk BehaviorsScienceServicesSexual HealthSexual TransmissionSexualitySocial DiscriminationStatutes and LawsStigmatizationStimulantStrategic PlanningStudy modelsSubstance Use DisorderSurveysTestingTrainingTranslatingUnsafe SexVulnerable PopulationsWorkamphetamine usebiobehaviorcomparative effectiveness trialexperiencehealth communicationhigh riskimprovedinformation gatheringinnovationinterestmHealthmarginalizationmenmen who have sex with menmobile computingpilot testpre-exposure prophylaxispreferenceprevention servicepreventive interventionprogramsprovider communicationpublic health researchscale upservice deliverysexskillssmartphone applicationsocial stigmastimulant usesubstance usesyndemictherapy designtherapy developmenttransmission processuptakevirtual
项目摘要
Abstract
Malaysia's HIV epidemic is rapidly expanding with recent evidence suggesting accelerated sexual
transmission, especially among men who have sex with men (MSM): 10% in 2008 to 54% in 2016. Biobehavioral
surveys suggest high HIV prevalence in MSM being nationally (21.6%) and in Kuala Lumpur (43%). This growing
epidemic in MSM is associated with condomless sex (CS), STIs, and high usage of substance (particularly
amphetamine-type stimulants; ATS). In Malaysia, both substance use and homosexuality are criminalized,
making MSM dually bear the burden of social stigma and discrimination, including in healthcare. Consequently,
they are marginalized from traditional, venue-based HIV prevention services, which undermines
recommendations by international agencies. To address stigma and discrimination, mHealth (mobile technology
to promote health) strategies can deliver prevention messages and guide health decisions anonymously, and thus
hold great promise for MSM, especially those using ATS. They can overcome barriers along the HIV prevention
cascade that now includes pre-exposure prophylaxis (PrEP). Combined with strong training and mentoring, the
proposed projects directly address this need through the conduct of two formative studies. First, information
about MSM's preferences of various attributes of PrEP delivery programs, including segmentation of ATS-using
MSM, will be assessed. Then, building on the first study, the candidate will develop and test an mHealth-based
intervention to overcome barriers along the prevention continuum, including HIV testing, co-occurring sexual
and drug risk behaviors and PrEP uptake among Malaysian MSM. Findings from these related projects will
provide the candidate with the necessary skills and competencies to develop and test an innovative and tailored
primary HIV prevention intervention for MSM. This K01 application for Dr. Shrestha is well-suited to advance
the career of the candidate by virtue of his training in intervention design, delivery, and placement, his high
productivity in public health research, and his evolving experience with research in the Malaysian context. Over
5 years, he will achieve new skills and experiences to achieve his professional goals and objectives to: 1) gain
experience in decision science with advanced quantitative and qualitative skills to become an independent
investigator in HIV, substance use, and mHealth intervention for vulnerable populations; 2) develop expertise
in mHealth intervention development, testing, implementation, and dissemination that will address specific
barriers to HIV prevention services in MSM, especially those with substance use disorders; and 3) develop an
independent career path focusing on HIV prevention in MSM using mHealth strategies. To achieve these goals,
he has assembled a stellar interdisciplinary team of mentors with expertise in HIV, substance use, intervention
design, decision science, advanced biostatistics, and mHealth research. Under their guidance, he will complete
relevant didactic work and attend seminars and conduct research to apply the skills needed to become an
independent researcher in mHealth-based HIV prevention among MSM.
抽象的
马来西亚的艾滋病毒流行正在迅速扩大,最近的证据表明性行为加速
传播,尤其是男男性行为者 (MSM) 中的传播:2008 年为 10%,2016 年为 54%。
调查显示,全国(21.6%)和吉隆坡(43%)的男男性行为者的艾滋病毒感染率很高。这种不断增长的
MSM 中的流行病与无套性行为 (CS)、性传播感染和大量使用物质(特别是
安非他明类兴奋剂;苯丙胺类兴奋剂)。在马来西亚,药物滥用和同性恋均被定为犯罪,
使男男性行为者双重承受社会耻辱和歧视的负担,包括在医疗保健方面。最后,
他们在传统的、基于场所的艾滋病毒预防服务中被边缘化,这损害了
国际机构的建议。为了解决耻辱和歧视问题,移动医疗(移动技术
促进健康)策略可以匿名传递预防信息并指导健康决策,从而
对于 MSM,尤其是那些使用 ATS 的 MSM 来说,前景广阔。他们可以克服艾滋病毒预防过程中的障碍
现在包括暴露前预防 (PrEP) 的级联反应。结合强有力的培训和指导,
拟议项目通过进行两项形成性研究直接满足这一需求。一、信息
关于 MSM 对 PrEP 实施方案各种属性的偏好,包括 ATS 使用的细分
MSM,将被评估。然后,在第一项研究的基础上,候选人将开发并测试基于移动医疗的
克服预防连续过程中的障碍的干预措施,包括艾滋病毒检测、同时发生的性行为
马来西亚 MSM 中的药物风险行为和 PrEP 吸收情况。这些相关项目的调查结果将
为候选人提供必要的技能和能力来开发和测试创新和定制的
MSM 的初级艾滋病毒预防干预。 Shrestha 博士的 K01 申请非常适合推进
候选人的职业生涯取决于他在干预设计、实施和安置方面的培训,他的高
公共卫生研究的生产力,以及他在马来西亚背景下不断发展的研究经验。超过
5年内,他将获得新的技能和经验,以实现他的职业目标和目的:1)获得
拥有先进的定量和定性技能的决策科学经验,成为独立的决策者
艾滋病毒、药物滥用和弱势群体移动健康干预领域的调查员; 2)发展专业知识
移动医疗干预措施的开发、测试、实施和传播,将解决特定问题
MSM 中艾滋病毒预防服务的障碍,特别是那些患有物质使用障碍的人; 3)开发一个
独立的职业道路,重点是使用移动医疗策略预防男男性行为者的艾滋病毒。为了实现这些目标,
他组建了一支出色的跨学科导师团队,拥有艾滋病毒、药物滥用、干预方面的专业知识
设计、决策科学、先进生物统计学和移动医疗研究。在他们的指导下,他将完成
相关的教学工作,参加研讨会和进行研究,以应用成为一名
男男性接触者中基于移动医疗的艾滋病毒预防的独立研究员。
项目成果
期刊论文数量(54)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Suicidal ideation, plan, and attempt among men who have sex with men in Nepal: Findings from a cross-sectional study.
- DOI:10.1371/journal.pgph.0002348
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Using individual stated-preferences to optimize HIV self-testing service delivery among men who have sex with men (MSM) in Malaysia: results from a conjoint-based analysis.
- DOI:10.1186/s12889-020-09832-w
- 发表时间:2020-11-25
- 期刊:
- 影响因子:4.5
- 作者:Shrestha R;Alias H;Wong LP;Altice FL;Lim SH
- 通讯作者:Lim SH
Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
- DOI:10.1016/j.drugpo.2021.103558
- 发表时间:2022-03
- 期刊:
- 影响因子:4.4
- 作者:Bachireddy, Chethan;Shrestha, Roman;Bromberg, Daniel J.;Azbel, Lyu;Kurmanalieva, Ainura;Wegman, Martin;Shumskaya, Natalya;Rozanova, Julia;Meyer, Jaimie P.;Altice, Frederick L.
- 通讯作者:Altice, Frederick L.
Feasibility and Acceptability of an mHealth-Based Approach as an HIV Prevention Strategy Among People Who Use Drugs on Pre-Exposure Prophylaxis.
基于移动医疗的方法作为艾滋病毒预防策略在使用药物进行暴露前预防的人群中的可行性和可接受性。
- DOI:10.2147/ppa.s236794
- 发表时间:2020
- 期刊:
- 影响因子:2.2
- 作者:Shrestha,Roman;Altice,FrederickL;DiDomizio,Elizabeth;Sibilio,Brian;Ranjit,YerinaS;Copenhaver,MichaelM
- 通讯作者:Copenhaver,MichaelM
Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder.
- DOI:10.1016/j.jsat.2021.108387
- 发表时间:2021-10
- 期刊:
- 影响因子:3.9
- 作者:Mistler CB;Sullivan MC;Copenhaver MM;Meyer JP;Roth AM;Shenoi SV;Edelman EJ;Wickersham JA;Shrestha R
- 通讯作者:Shrestha R
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roman Shrestha其他文献
Roman Shrestha的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roman Shrestha', 18)}}的其他基金
Integrated online-to-offline (O2O) model of care for HIV prevention and treatment among men who have sex with men
男男性行为者艾滋病预防和治疗的线上线下(O2O)一体化护理模式
- 批准号:
10548402 - 财政年份:2022
- 资助金额:
$ 18.14万 - 项目类别:
Integrated online-to-offline (O2O) model of care for HIV prevention and treatment among men who have sex with men
男男性行为者艾滋病预防和治疗的线上线下(O2O)一体化护理模式
- 批准号:
10665762 - 财政年份:2022
- 资助金额:
$ 18.14万 - 项目类别:
An online HIV self-testing intervention with online-to-offline linkage to care for transgender women
在线艾滋病自检干预,线上线下联动,关爱跨性别女性
- 批准号:
10772677 - 财政年份:2022
- 资助金额:
$ 18.14万 - 项目类别:
Improving HIV testing and PrEP for transgender women through mHealth
通过移动医疗改善跨性别女性的艾滋病毒检测和 PrEP
- 批准号:
10258220 - 财政年份:2021
- 资助金额:
$ 18.14万 - 项目类别:
Development and Testing of a Mobile Application to Enhance HIV Prevention Cascade in Malaysian MSM
开发和测试移动应用程序以加强马来西亚男男性接触者的艾滋病毒预防级联
- 批准号:
10367278 - 财政年份:2021
- 资助金额:
$ 18.14万 - 项目类别:
Improving HIV testing and PrEP for transgender women through mHealth
通过移动医疗改善跨性别女性的艾滋病毒检测和 PrEP
- 批准号:
10398983 - 财政年份:2021
- 资助金额:
$ 18.14万 - 项目类别:
Development and Testing of a Mobile Application to Enhance HIV Prevention Cascade in Malaysian MSM
开发和测试移动应用程序以加强马来西亚男男性接触者的艾滋病毒预防级联
- 批准号:
10261542 - 财政年份:2021
- 资助金额:
$ 18.14万 - 项目类别:
Development and Testing of a Mobile Application to Enhance HIV Prevention Cascade in Malaysian MSM
开发和测试移动应用程序以加强马来西亚男男性接触者的艾滋病毒预防级联
- 批准号:
10673162 - 财政年份:2020
- 资助金额:
$ 18.14万 - 项目类别:
Integrated rapid access to HIV prevention program for people who inject drugs (iRaPID)
注射吸毒者综合快速获得艾滋病毒预防计划 (iRaPID)
- 批准号:
10082915 - 财政年份:2020
- 资助金额:
$ 18.14万 - 项目类别:
Integrated Rapid Access to HIV Prevention Program for People Who Inject Drugs (RAPID)
注射吸毒者综合快速艾滋病毒预防计划 (RAPID)
- 批准号:
10224917 - 财政年份:2020
- 资助金额:
$ 18.14万 - 项目类别:
相似国自然基金
高功率激光驱动低β磁重联中磁岛对电子加速影响的研究
- 批准号:12305275
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
U型离散顺流火蔓延非稳态热输运机理与加速机制研究
- 批准号:52308532
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
实施科学视角下食管癌加速康复外科证据转化障碍机制与多元靶向干预策略研究
- 批准号:82303925
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TWIST1介导的ITGBL1+肿瘤相关成纤维细胞转化加速结肠癌动态演化进程机制及其预防干预研究
- 批准号:82373112
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
NOTCH3/HLF信号轴驱动平滑肌细胞表型转化加速半月板退变的机制研究
- 批准号:82372435
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023
IAS 2023,第 12 届 IAS HIV 科学会议,澳大利亚布里斯班,虚拟会议,2023 年 7 月 23-26 日
- 批准号:
10696505 - 财政年份:2023
- 资助金额:
$ 18.14万 - 项目类别:
Developing a Risk Index for Functional Decline in Middle-Aged and Older Adults with HIV
制定中老年艾滋病毒感染者功能衰退的风险指数
- 批准号:
10762280 - 财政年份:2023
- 资助金额:
$ 18.14万 - 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM) Research Core & MHD-CE
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686545 - 财政年份:2023
- 资助金额:
$ 18.14万 - 项目类别:
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
CAPRISA CASCADE 临床试验网络临床研究网站
- 批准号:
10754981 - 财政年份:2023
- 资助金额:
$ 18.14万 - 项目类别: